These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 25537462)

  • 1. Plasma visfatin/nicotinamide phosphoribosyltransferase levels in hypertensive elderly - results from the PolSenior substudy.
    Kocelak P; Olszanecka-Glinianowicz M; Owczarek A; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Zdrojewski T; Grodzicki T; Więcek A; Chudek J
    J Am Soc Hypertens; 2015 Jan; 9(1):1-8. PubMed ID: 25537462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma visfatin/nicotinamide phosphoribosyltransferase (visfatin/NAMPT) concentration in elderly subjects with metabolic syndrome.
    Kocełak P; Olszanecka-Glinianowicz M; Owczarek AJ; Krupa W; Obirek P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Zdrojewski T; Skalska A; Więcek A; Chudek J
    Pol Arch Med Wewn; 2015; 125(6):402-13. PubMed ID: 25924024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between circulating visfatin/NAMPT, nutritional status and insulin resistance in an elderly population - results from the PolSenior substudy.
    Olszanecka-Glinianowicz M; Owczarek A; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Zdrojewski T; Grodzicki T; Więcek A; Chudek J
    Metabolism; 2014 Nov; 63(11):1409-18. PubMed ID: 25172122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma visfatin/nicotinamide phosphoribosyltransferase (visfatin/NAMPT) concentration is not related to kidney function in elderly subjects.
    Kocelak P; Olszanecka-Glinianowicz M; Owczarek A; Bozentowicz-Wikarek M; Brzozowska A; Mossakowska M; Skalska A; Wiecek A; Chudek J
    Clin Chem Lab Med; 2015 Apr; 53(5):793-9. PubMed ID: 25274953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between circulating visfatin/nicotinamide phosphoribosyltransferase, obesity, inflammation and lipids profile in elderly population, determined by structural equation modeling.
    Owczarek AJ; Olszanecka-Glinianowicz M; Kocełak P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Puzianowska-Kuźnicka M; Grodzicki T; Więcek A; Chudek J
    Scand J Clin Lab Invest; 2016 Dec; 76(8):632-640. PubMed ID: 27712122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids.
    Chang YC; Chang TJ; Lee WJ; Chuang LM
    Metabolism; 2010 Jan; 59(1):93-9. PubMed ID: 19765775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism.
    Chu CH; Lee JK; Wang MC; Lu CC; Sun CC; Chuang MJ; Lam HC
    Metabolism; 2008 Oct; 57(10):1380-3. PubMed ID: 18803942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipocytes as a source of increased circulating levels of nicotinamide phosphoribosyltransferase/visfatin in active acromegaly.
    Olarescu NC; Ueland T; Lekva T; Dahl TB; Halvorsen B; Aukrust P; Bollerslev J
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1355-62. PubMed ID: 22319029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated visfatin levels in obese children are related to proinflammatory factors.
    Li RZ; Ma Xn; Hu XF; Kang SX; Chen SK; Cianflone K; Lu HL
    J Pediatr Endocrinol Metab; 2013; 26(1-2):111-8. PubMed ID: 23327785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating visfatin level is correlated with inflammation, but not with insulin resistance.
    Oki K; Yamane K; Kamei N; Nojima H; Kohno N
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):796-800. PubMed ID: 17634078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visfatin/PBEF/Nampt and resistin expressions in circulating blood monocytes are differentially related to obesity and type 2 diabetes in humans.
    Laudes M; Oberhauser F; Schulte DM; Freude S; Bilkovski R; Mauer J; Rappl G; Abken H; Hahn M; Schulz O; Krone W
    Horm Metab Res; 2010 Apr; 42(4):268-73. PubMed ID: 20091460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
    de Boer JF; Bahr MJ; Böker KH; Manns MP; Tietge UJ
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G196-201. PubMed ID: 19074645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visfatin is associated with lipid metabolic abnormalities in Lyon hypertensive rats.
    Wang P; Bai C; Xu QY; Xu TY; Su DF; Sassard J; Miao CY
    Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):894-9. PubMed ID: 20456420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of sodium restricted diet on plasma visfatin levels in hypertensive patients with visceral obesity.
    Rotkegel S; Chudek J; Spiechowicz-Zaton U; Ficek R; Adamczak M; Wiecek A
    Kidney Blood Press Res; 2013; 37(2-3):124-31. PubMed ID: 23615125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between tissue visfatin/nicotinamide, phosphoribosyltransferase (Nampt), retinol binding protein-4, and vaspin concentrations and insulin resistance in morbidly obese subjects.
    Goktas Z; Owens S; Boylan M; Syn D; Shen CL; Reed DB; San Francisco S; Wang S
    Mediators Inflamm; 2013; 2013():861496. PubMed ID: 24367155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinol-binding protein 4 and nicotinamide phosphoribosyltransferase/visfatin in rat obesity models.
    Mercader J; Granados N; Caimari A; Oliver P; Bonet ML; Palou A
    Horm Metab Res; 2008 Jul; 40(7):467-72. PubMed ID: 18401839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy.
    Luizon MR; Palei ACT; Belo VA; Amaral LM; Lacchini R; Duarte G; Cavalli RC; Sandrim VC; Tanus-Santos JE
    Pharmacogenomics J; 2017 Oct; 17(5):427-434. PubMed ID: 27168100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma visfatin concentrations increase in both hyper and hypothyroid subjects after normalization of thyroid function and are not related to insulin resistance, anthropometric or inflammatory parameters.
    Caixàs A; Tirado R; Vendrell J; Gallart L; Megía A; Simón I; Llauradó G; González-Clemente JM; Giménez-Palop O
    Clin Endocrinol (Oxf); 2009 Nov; 71(5):733-8. PubMed ID: 19222486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy.
    Alghasham AA; Barakat YA
    Saudi Med J; 2008 Feb; 29(2):185-92. PubMed ID: 18246224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-B cell colony enhancing factor/NAMPT/visfatin and its role in inflammation-related bone disease.
    Moschen AR; Geiger S; Gerner R; Tilg H
    Mutat Res; 2010 Aug; 690(1-2):95-101. PubMed ID: 19583971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.